Marksans Pharma Limited (MARKSANS) Share Price & AI Investment Analysis

Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeuti. Track Marksans Pharma Limited's live NSE:MARKSANS share price ₹336.60 (-3.16%), market cap ₹₹153B, P/E 28.3. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for MARKSANS — real-time NSE India stock intelligence.